Group items tagged

Breastlight is a breast screening product for women with the help of which they can find early symptoms and more details about breast cancer awareness.

Breastlight is a product that allows you to see inside your breasts. It works by shining a powerful light through the breast tissue. It is completely safe and easy to use. Over 80% of women have told us they feel more confident when using Breastlight as part of their breast awareness routine.

Statistics show that 1 in 8 women will develop breast cancer at some point in their lives. While this disease can be deadly, it is also preventable. This blog post will discuss six things you need to know about breast cancer prevention. Knowledge is power when it comes to fighting cancer, so read on and learn how you can protect yourself. UNDERGO ROUTINE CHECKUPS One of the first things you can do to prevent breast cancer is to undergo routine checkups. This means going for mammograms and clinical breast exams regularly. In this case, your doctor may even recommend using ultrasound technology to get a clear picture of the breast tissue. Rest assured that your doctor will be able to detect any changes in your breasts and will be able to determine if there is anything to worry about. The earlier you catch any abnormalities, the better your chances of beating cancer. BE AWARE OF YOUR FAMILY HISTORY Another important factor to consider is your family history. If you have close relatives who have been diagnosed with breast cancer, your risk may be higher. This is because some forms of breast cancer can be hereditary. As such, it is important to be aware of your family history and to let your doctor know if there is a history of breast cancer in your family. From there, you should discuss your options with your doctor and make sure to get regular screenings. More often than not, early detection is key when it comes to surviving breast cancer which is why family history is so important.

The NHS has secured a deal for 'Pembrolizumab' to treat women with triple-negative breast cancer. Up to 1,600 women a year affected by high risk triple-negative breast cancer are set to benefit from the confidential deal struck by the NHS and the Merck Sharp and Dohme's (MSD), manufacturer of Pembrolizumab. Triple-negative breast cancer affects around 8,000 women a year - accounting for 15% of all breast cancer cases. This will be the 25th breast cancer treatment fast-tracked to patients through funding from the Cancer Drugs Fund and the second treatment for triple negative breast cancer to be introduced this year on the NHS. NHS chief executive, Amanda Pritchard, said: "This is a hugely significant moment for women - the NHS has struck a new deal to roll out a potentially life-saving drug for patients suffering with the most aggressive form of breast cancer that has been traditionally very difficult to treat.

The National Institute for Health and Care Excellence (NICE) has recommended pembrolizumab in combination with chemotherapy (paclitaxel or nab-paclitaxel) which is said to benefit people with triple negative breast cancer. Clinical trial evidence shows that, compared with paclitaxel, pembrolizumab combination increases how long people have before their cancer gets worse and how long they live. NICE already recommends atezolizumab in combination with chemotherapy for untreated PD-L1-positive, locally advanced or metastatic, triple-negative breast cancer. Atezolizumab combination is recommended by NICE for people with IC equal to or greater than 1%. "This means that some people who can't have atezolizumab combination could be eligible for pembrolizumab combination," said NICE. NICE's independent appraisal committee also agreed that the pembrolizumab combination meets the higher cost-effectiveness threshold for life-extending treatments for people with a short life expectancy. Given by injection every 3 weeks, pembrolizumab (also called Keytruda and made by Merck Sharp and Dohme) is a type of immunotherapy that specifically targets triple negative breast cancer. It works by blocking the activity of a protein known as PD-L1 which is produced in larger amounts on cancerous cells than normal cells. By blocking PD-L1 it helps the person's own immune cells to attack the cancer.

A groundbreaking study analysing data from nearly 600,000 cancer patients in England has shed light on the increased risk of second cancers among breast cancer survivors. The research conducted by University of Cambridge in association with the Lancet Regional Health-Europe studied data from over 580,000 female and over 3,500 male breast cancer survivors diagnosed between 1995 and 2019 using the National Cancer Registration Dataset. The findings suggest that survivors of breast cancer, the most prevalent cancer in the UK, face a substantially higher risk of developing second primary cancers. According to the research, female survivors exhibited a twofold increase in the risk of contralateral breast cancer compared to the general population. The data highlighted an 87 per cent greater risk of endometrial cancer, a 58 per cent greater risk of myeloid leukemia, and a 25 per cent greater risk of ovarian cancer in female survivors.

The Medicines and Healthcare Products Regulatory Agency (MHRA) has approved Anastrozole in a new use to prevent the disease. The off-patent drug has been used as a breast cancer treatment for many years. Clinical trials have shown that it can reduce the incidence of breast cancer in post-menopausal women with increased risk by almost 50 per cent. Health Minister Will Quince expressed his happiness on the approval of the drug that can help to prevent this "cruel disease". He said: "We've already seen the positive effect Anastrozole can have in treating the disease when it has been detected in post-menopausal women and now we can use it to stop it developing at all in some women.

Breast augmentation procedure is designed to enhance the size and fullness of the breasts, usually with breast implants. If you are unhappy with the appearance of your breasts because they are smaller in size or they have lost their volume or shape due to pregnancy or rapid weight fluctuations, you might consider a breast augmentation to get the breasts of your desire.

The National Institute of Health and Care Excellence has recommended that surgeons working in hospitals with limited or no access to a radiopharmacy department could now use Magtrace and Sentimag as an option to locate sentinel lymph nodes in people with breast cancer. The recommendation in draft NICE medical technology guidance could see a change in NHS standard care for the first time in years. The technology could also mitigate the reliance on radioactive isotope tracers shipped in from outside Great Britain. The magnetic liquid tracer - Magtrace - is a non-radioactive dark brown liquid. It is both a magnetic marker and a visual dye. The Magtrace is injected into the tissue around a tumour. The particles are then absorbed into the lymphatic system, following the route that cancer cells are most likely to take when they spread from the primary tumour and become trapped in sentinel lymph nodes. The Sentimag probe moves over the skin emitting sounds of different pitches as it passes over the Magtrace tracer, in a similar way to a metal detector locating metal in the ground. The nodes often appear dark brown or black in colour, which also helps with identification.

There are several causes thanks to which breast actives is gaining popularity. This can be a natural item, beside this reality it'll offer you speedy and stable outcomes. There is certainly no reaction or any irritation on skin that is a common trouble any time you take the treatment like cosmetic surgery or breasts implants.

Breast Actives Official Website - If You are searching Breast Actives Official Website to Buy Breast Actives then you are at right place to Buy Here!

It's hard to believe it's been 20 years since Avon started its Breast Cancer Crusade and made pink synonymous with breast cancer in our consciousness. With industries as diverse as professional sports and designer fashion taking part in the cause, Avon's advocacy has turned into a true worldwide effort.

How to increase breast size? Is a big major problem Big Bxl breast growth capsule is available in both cream and capsule form.

breast cancer is a widespread disease similarly there are certain rumors about the disease that are frequently circulating such as a recent rumor is that use of antiperspirants causes breast cancer in women, but no evidence in this regard is provided. There are certain more misconceptions about the disease revolving among the masses and causing needless anxiety.

Breast cancer is a global epidemic as it affects a number of women around the globe each year. Scientist and researchers are putting in their efforts to find a way through which the cancer can be defeated or its occurrence can be prevented, but unfortunately nobody is succeeded yet in this regard however many ways have been discovered which can help reducing the risk to be affected by the disease or the cancer can be prevented.

Women are advised to be in touch with their breasts due to increased risk of getting the breast cancer as the risk is same for women around the globe so they asked to enlighten their awareness on regular basis and it is possible by staying in touch with this part of the body so that they can become familiar with their breasts as several changes take place in this part of the body throughout the life. breast awareness

Breast cancer has become a global epidemic due to various unknown reasons, however many studies have been conducted to find out the reasons of breast cancer but no absolute reason has been found yet.

A large number of tests are used to diagnose the cancer at initial stage and doctors try to determine that which tests are effective to treat the cancer successfully as it is not easy to treat the cancer successfully because it is a group of almost hundred diseases characterized by the uncontrolled growth of cells which form a lump or tumor that can be benign as well as malignant and the malignant tumor invades the other parts of the body while benign tumors don't spread to the other parts of the body. Breast Cancer

Women being the delicate creature are at increased risk of developing cancer as compare to men and the difference between the breast of men and women is that both have different breast structure as women breast are made up of many breast tissues which include connective, fatty and glandular tissues and the difference of structure start developing at the time of puberty as after puberty women breasts become larger and developed to perform different functions such as to maintain attractive physique, produce milk for infants and give pleasure to the partner during sex.

Breast cancer is a disease that is caused by the formation of cancerous cells in one breast or the other. This type of cancer far exceeds than other types of cancer as it affects a large number of women in every corner of the world regardless of the age and race.

As breast cancer is known as a silent killer so most of the times there are no outwards sign of this cancer; however some of the outward signs are lumps, thickening of breast tissue or a dimple in breast and some of the uncommon signs are redness, swelling or enlarged lymph node in the armpit although in presence of these signs it's not confirm that a woman has breast cancer because these signs can take place in case of other abnormalities as well as women breasts are prone to change throughout the life so women should be aware of the certain changes which normally take place during the course of life so that she can identify abnormal changes that may be diagnosed as breast cancer symptoms at some stage of life.